EARLY-STAGE ALZHEIMER'S DISEASE AUTOANTIBODY BIOMARKERS, TARGET ANTIGENS, AND DIAGNOSTIC USES THEREOF

摘要

The present invention provides methods, compositions and kits for the detection of Early-Stage Alzheimer's disease (AD) autoantibody biomarkers, for the diagnosis of Early-Stage AD, for the identification of a subject at risk for developing Early-Stage AD, and for the generation of patient-specific Early-Stage AD autoantibody biomarker profiles.